Home › Funds › LAKEWOOD CAPITAL MANAGEMENT, LP › ELV

LAKEWOOD CAPITAL MANAGEMENT, LP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

LAKEWOOD CAPITAL MANAGEMENT, LP reported holding 55,850 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$21.7M, representing 1.16% of its reported portfolio and ranking #31 among its reported holdings. LAKEWOOD CAPITAL MANAGEMENT, LP has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)55.85K sh
Reported value held$21.72M
Portfolio Weight1.16%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How LAKEWOOD CAPITAL MANAGEMENT, LP's ELV position evolved

LAKEWOOD CAPITAL MANAGEMENT, LP first disclosed a stake in ELV in Q3 2023 at 62,000 shares (US$27.0M). The position peaked in Q3 2025 at 301,650 shares, worth US$97.5M. Across 13 filings, LAKEWOOD CAPITAL MANAGEMENT, LP increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 55,850 shares valued at US$21.7M — a reduction of -3,500 shares quarter over quarter.. Notable position changes include a 80% increase in Q4 2024 (shares rose 18% over the following quarter), a 49% increase in Q3 2025 (shares rose 9% over the following quarter), a 60% trim in Q4 2025 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 62.00K $27.00M New
Q4 2023 62.00K $29.24M Hold
Q1 2024 78.00K $40.45M Add
Q2 2024 83.00K $44.97M Add
Q3 2024 99.50K $51.74M Add
Q4 2024 178.65K $65.90M Add
Q1 2025 190.15K $82.71M Add
Q2 2025 202.15K $78.63M Add
Q3 2025 301.65K $97.47M Add
Q4 2025 121.85K $42.71M Reduce
Q1 2026 112.35K $32.89M Reduce
Q2 2026 59.35K $22.95M Reduce
Q3 2026 55.85K $21.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.31B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has LAKEWOOD CAPITAL MANAGEMENT, LP held ELV?

LAKEWOOD CAPITAL MANAGEMENT, LP has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LAKEWOOD CAPITAL MANAGEMENT, LP's current position in ELV?

As of Q3 2026, LAKEWOOD CAPITAL MANAGEMENT, LP holds 55.85K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $21.72M, representing 1.16% of its reported portfolio and ranking #31.

Has LAKEWOOD CAPITAL MANAGEMENT, LP been buying or selling ELV?

In the latest 13F filing (Q3 2026), LAKEWOOD CAPITAL MANAGEMENT, LP reduced its position in ELV. The position peaked in Q3 2025 at 301.65K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.